The increasing prevalence of benign prostatic hyperplasia (BPH) and other urinary tract disorders is driving demand for prostatic stents, but the market also faces several challenges. Potential complications such as stent migration, encrustation, infection, and patient discomfort can limit long-term use. In addition, stringent regulatory requirements, the availability of alternative...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek